TG Therapeutics, Inc.
USD55.95
+0.23 (+0.41%)
CEO
Michael S. Weiss
IPO Date
2010-05-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$55.89
Prev. Close
$55.72
Day Low
$54.50
Day High
$56.20
52W Low
$25.28
52W High
$57.38
Market Cap
$8.57B
Volume
0.47M
| 187.1 |
| 31 Dec 2023 | FY | 94.0% | 5.4% | 7.9% | 3.8% | 0.69 | 5.92 | 191.3 |
| 31 Dec 2022 | FY | 90.5% | -8036.3% | -382.0% | -115.6% | 1.42 | 3.16 | -7.2 |
| 31 Dec 2021 | FY | 88.2% | -5204.1% | -146.8% | -91.7% | 0.33 | 5.06 | -7.2 |
| 31 Dec 2020 | FY | 100.0% | -183803.3% | -53.8% | -44.7% | 0.08 | 6.99 | -21.5 |
| 31 Dec 2019 | FY | 100.0% | -113730.9% | -447.7% | -106.0% | 1.06 | 1.77 | -5.7 |
| 31 Dec 2018 | FY | 42.1% | -114132.9% | -721.8% | -207.5% | 0.00 | 2.03 | -1.8 |
| 31 Dec 2017 | FY | 46.0% | -77749.9% | -176.8% | -121.7% | 0.00 | 3.34 | -4.3 |
| 31 Dec 2016 | FY | 58.7% | -51353.4% | -218.2% | -142.8% | 0.00 | 3.01 | -2.9 |
| 46.2 |
| 30 Sept 2025 | Q3 | 82.6% | 241.7% | 64.4% | 38.1% | 0.42 | 3.82 | 3.4 |
| 30 Jun 2025 | Q2 | 86.6% | 20.0% | 10.2% | 4.0% | 0.92 | 3.86 | 46.8 |
| 31 Mar 2025 | Q1 | 87.1% | 4.2% | 2.1% | 0.8% | 1.07 | 4.02 | 285.7 |
| 31 Dec 2024 | Q4 | 85.8% | 21.6% | 10.5% | 4.0% | 1.14 | 6.25 | 46.8 |
| 30 Sept 2024 | Q3 | 88.9% | 4.6% | 2.0% | 0.7% | 1.32 | 4.59 | 218.7 |
| 30 Jun 2024 | Q2 | 88.7% | 9.4% | 3.9% | 1.7% | 0.63 | 3.58 | 95.5 |
| 31 Mar 2024 | Q1 | 91.3% | -16.9% | -6.7% | -2.9% | 0.70 | 3.62 | -50.4 |
| 31 Dec 2023 | Q4 | 81.9% | -32.8% | -9.0% | -4.4% | 0.69 | 5.92 | -42.4 |